金斯瑞生物(01548.HK) 公布,计划配售7,712.6万股新股,占扩大后已发行股本约3.38%,配售价每股30.5元,较昨日(10日)收市价32元折让约4.7%。假设悉数配售,所得款项总额约23.52亿元,所得净额约23.27亿元,当中约70%用于扩大集团AIDD平台的产能和基础设施;约20%用于与该AIDD平台相关的研发、数字化工作流程整合及全球业务拓展;余下约10%将用作一般公司用途及...
Source Link金斯瑞生物(01548.HK) 公布,计划配售7,712.6万股新股,占扩大后已发行股本约3.38%,配售价每股30.5元,较昨日(10日)收市价32元折让约4.7%。假设悉数配售,所得款项总额约23.52亿元,所得净额约23.27亿元,当中约70%用于扩大集团AIDD平台的产能和基础设施;约20%用于与该AIDD平台相关的研发、数字化工作流程整合及全球业务拓展;余下约10%将用作一般公司用途及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.